Status:
COMPLETED
Hyperbaric Oxygen Therapy Induced Neuroplasticity in Post Stroke Patients Suffering Chronic Neurological Deficiencies
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
Chronic Neurological Deficiency
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the current work was to evaluate, for the first time in a prospective randomized study, the effect of HBOT on patients with chronic neurological deficiency due to stroke.
Detailed Description
Objective: Evaluate the effect of hyperbaric oxygen therapy (HBOT) on patients with chronic neurological deficiency due to stroke. Methods: A prospective, randomized, control-crossed over trial inclu...
Eligibility Criteria
Inclusion
- Age 18 years or older, who had ischemic stroke and 60 patients who had hemorrhagic stroke 6-18 months prior to their inclusion in the study.
Exclusion
- Dynamic neurologic improvement or worsening during the last 4 weeks.
- Had been treated with HBO for any other reason prior to their inclusion.
- Have any other indication for HBOT
- Chest pathology incompatible with pressure changes
- Inner ear disease
- Patients suffering from claustrophobia.
- Inability to give written informed consent.
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT00715897
Start Date
August 1 2008
End Date
November 1 2011
Last Update
December 26 2011
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Asaf-Harofeh Medical Center
Ẕerifin, Israel, 70300
2
Research & Development unit, Asaf-Harofeh Medical Center
Ẕerifin, Israel, 70300